XML 37 R18.htm IDEA: XBRL DOCUMENT v3.25.1
Cash and cash equivalents
12 Months Ended
Dec. 31, 2024
Cash and cash equivalents  
Cash and cash equivalents

Note 11. Cash and cash equivalents

​

​

​

​

​

​

​

​

​

​

As of December 31, 

(in thousands of euros)

    

2022

    

2023

    

2024

Other cash equivalents(1)

 

16,798

​

17,933

​

70,655

Cash at bank and at hand

 

69,939

​

8,985

​

25,908

Cash and cash equivalents

 

86,736

​

26,918

​

96,564

(1)Other cash equivalents correspond to short term bank deposits.

​

As of December 31, 2024, cash and cash equivalents amounted to €96.6 million compared to €26.9 million as of December 31, 2023, an increase of €69.6 million due to a net cash used in operating activities of €85.9 million, a net cash generated by investing activities of €8.7 million, and a net cash generated by financing activities of €145.6 million.

For the period ended December 31, 2024, the net cash generated from financing activities amounted to €145.6 million, compared to €29.1 million in 2023. The change is due to the receipt of:

●The second tranche of €25 million drawn in January 2024 under the Finance Contract with the EIB,
●Aggregate gross proceeds of €20.1 million (net proceeds €19.7 million) from the issuance of 2024 Royalty Certificates in July 2024,
●Aggregate gross proceeds of €94.1 million (net proceeds €86.2 million) from the issuance of ordinary shares and prefunded warrants in October 2024 as part of the Structured Financing,
●Aggregate gross proceeds of €21.4 million (net proceeds €19.8 million) from the issuance of ordinary shares and prefunded warrants in December 2024 as part of the Structured Financing.

(see Note 1.2. – Significant events of 2024).